Ophthalmology Times Europe Newsletter

To view this email as a web page, click here.

Submicron formula ‘step forward’ in steroid therapy

Loteprednol etabonate ophthalmic gel 0.38% (Lotemax SM, Bausch + Lomb) is a new iteration of the topical corticosteroid with a number of benefits for patients, said Marguerite B. McDonald, MD.

What attendees can expect at ARVO April 28th

ARVO Executive Director Iris Rush discusses what attendees can look forward to at this year’s event, which kicks off April 28.

Statins offer promise in ophthalmology

Statins may help treat ocular inflammation, and are generally safe, but clinicians should watch for rare, serious adverse events, researchers say.

Episode 2: Embracing AI in DR, glaucoma and at the podium

A small benefit from Brexit to Commonwealth ophthalmologists

Ultra-widefield imaging contributes to earlier disease detection

An international encyclopedic database for IOL specifications

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.